A new cohort study published in the Journal of the Endocrine Society has found that adults with type 2 diabetes who habitually sleep longer face a higher risk of developing or worsening diabetic kidney disease, complicating the usual advice that more sleep is uniformly better for metabolic health.
What the Study Found
Researchers followed 678 Japanese adults with type 2 diabetes for a mean of six years, measuring self-reported sleep duration at baseline, two years, and five years. Over the course of follow-up, 31.7% of participants developed or experienced worsening of diabetic nephropathy, the kidney damage that is among the most common and serious complications of long-term diabetes.
Participants who habitually slept seven or more hours per night had a higher risk of diabetic nephropathy developing or progressing compared with those who slept less, according to lead author Tomoya Mita and colleagues. The association was strongest in two subgroups: participants who already had microalbuminuria — an early marker of kidney damage — at baseline, and those aged 65 and older.
Why This Is Counterintuitive
Most sleep research links short sleep, not long sleep, to worse metabolic outcomes. Chronic short sleep has repeatedly been tied to insulin resistance, higher blood pressure, and elevated cardiovascular risk, and longer sleep duration is often promoted as a general health goal. This study adds to a smaller body of evidence suggesting the relationship between sleep duration and health outcomes is U-shaped rather than linear — with risk rising again at the long end of the sleep spectrum, not just the short end.
The researchers emphasized that their findings are observational and don't establish that long sleep itself damages the kidneys. Instead, they propose that longer habitual sleep in people with diabetes may be a marker of underlying vulnerability — for example, fatigue from early kidney dysfunction, inflammation, autonomic nerve damage, or other complications that cause someone to need more rest, rather than a cause of the kidney damage itself.
A Caution, Not a New Prescription
Mita was explicit that the results should not be read as license to cut sleep short. "People should not interpret our findings as a recommendation to reduce their sleep," he said, noting that short sleep carries its own well-documented risks in people with diabetes.
Instead, the authors suggest that unusually long sleep duration in a patient with type 2 diabetes — particularly an older patient or one who already shows early signs of kidney involvement — could serve as a clinical flag worth investigating further, rather than being dismissed as benign or beneficial.
What This Means for Patients
Diabetic kidney disease, also called diabetic nephropathy, is a leading cause of chronic kidney disease and dialysis dependence worldwide, and it often progresses silently before symptoms appear. For patients with type 2 diabetes, this study doesn't change the standard of care — blood sugar control, blood pressure management, and regular kidney function monitoring remain the primary tools for prevention.
But it does suggest that sleep duration is worth discussing with a physician as part of the broader clinical picture, especially for older patients or those with existing microalbuminuria. A patient who has started sleeping noticeably longer than they used to, without a clear lifestyle explanation, may want to flag that change at their next diabetes checkup rather than assume it's simply a sign of healthy rest. As with much of sleep epidemiology, the next step is research that can untangle cause from consequence — ideally through studies that track kidney biomarkers and sleep simultaneously over time, rather than relying on self-reported sleep duration alone.